Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Žhong Yuan's publication output changed over time?
ScholarIQpublication output · 1995–2024
Output declined50% over the shown period — from 2 works in 1995 to 1 in 2024.
2
1
1
2
1
1
1
1
1
199520002001200520152017201820202024
What are the most-cited papers on Žhong Yuan?
ScholarIQmost cited works
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
Scott M. Grundy, Gloria Lena Vega, Žhong Yuan, Wendy P. Battisti, William E. Brady, Joanne Palmisano
The American Journal of Cardiology. 2005310 Citations
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer
Milan Radovich, Guanglong Jiang, Bradley A. Hancock, Christopher R. Chitambar, Rita Nanda, Carla I. Falkson, Filipa Lynce, Christopher Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma Mahtani, Michael A. Thompson, Robert Graham, Maureen E. Cooper, Dean C. Pavlick, Lee A. Albacker, Jeffrey P. Gregg, Jeffrey P. Solzak, Yu-Hsiang Chen, Casey Bales, Erica Cantor, Fei Shen, Anna Maria Storniolo, Sunil Badve, Tarah J. Ballinger, Chun-Li Chang, Žhong Yuan, Cagri A. Savran, Kathy D. Miller, Bryan P. Schneider
JAMA Oncology. 2020307 CitationsOPEN ACCESS
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
Christie M. Ballantyne, Nicola Abate, Žhong Yuan, Thomas King, Joanne Palmisano
American Heart Journal. 2005240 Citations
Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor
Jacob A. Udell, Žhong Yuan, Toni Rush, Nicholas Sicignano, Michael S. Galitz, Norman Rosenthal
Circulation. 2017230 CitationsOPEN ACCESS
Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors
Christopher L. Taylor, Žhong Yuan, Warren R. Selman, Robert A. Ratcheson, Alfred A. Rimm
Journal of neurosurgery. 1995209 Citations
Related on ScholarIQ
Johnson & Johnson (United States)
Institution
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
Paper
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer
Paper
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
Paper
Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor
Paper
Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors
Paper